Evaluation of a Visual-Analog Scale (VAS) for Remote DBS Programming (The REMOTE-Trial)
Related Research units
Abstract
Patients & Methods: Within the scope of a prospective, randomized multicenter clinical trial (the REMOTE Trial), we will examine the effectiveness and safety of VAS-based remote DBS programming in PD by using a novel and recently introduced software platform (Abbott NeurosphereTM Virtual Clinic) that allows for the programming through a smartphone-based video connection with the patient. Therefore, n = 50 PD patients undergoing STN-DBS surgery will be randomized and subsequent to surgery will have their IPG settings adjusted either during regular visits at the hospital or alternatively be programmed remotely through a VAS-based approach.
Expected Results: Prior to surgery and after a 90 days follow-up period, we will assess specific clinical (MDS-UPDRS, PDQ-39, BDI, MOCA) parameters to determine the effectivity and safety of the two different strategies on the patient outcome and to correlate it with VAS ratings and MRI data (Fig. 1).
Conclusion: Our results will support the examination of remote-based DBS programming and evaluate the patient’s subjective judgment as a valid feedback signal.
References
1. Palleis, C., Gehmeyr, M., Mehrkens, J. H., Bötzel, K. & Koeglsperger, T. Establishment of a Visual Analog Scale for DBS Programming (VISUAL-STIM Trial). Front Neurol 11, 561323 (2020).
Fig. 1. Schematic illustrating the REMOTE Trial study protocol.
Download : Download high-res image (336KB)Download : Download full-size image
Bibliographical data
Original language | German |
---|---|
Title of host publication | Clinical Neurophysiology |
Volume | 137 |
Publication date | 05.2022 |
Pages | e43-e44 |
DOIs | |
Publication status | Published - 05.2022 |